Adverse Effects of Medicines : Is the Omani population safe? by Al-Saadoon, Muna
Sultan Qaboos University Med J, May 2015, Vol. 15, Iss. 2, pp. e149–151, Epub. 28 May 15
Submitted 26 Feb 15
Revision Req. 23 Mar 15; Revision Recd. 8 Apr 15
Accepted 16 Apr 15
In the current issue of SQUMJ, Jose et al. reported that approximately 46% of the participants in their study (n = 618) held the 
erroneous notion that adverse effects occurred only 
when medications were consumed in high doses.1 
Approximately 60% of their cohort endorsed the view 
that medicines prescribed by doctors are completely 
safe. Another most disheartening finding from the 
study was that the Omani public appeared to hold 
the view that traditional medicines and over-the-
counter medications were free of any side-effects.1 
In a nutshell, these findings could be extrapolated to 
indicate that the general public harbours sub-optimal 
knowledge, belief and behaviour on issues pertinent to 
the usage of medicine. 
Patient safety is an essential principle of healthcare. 
Each phase of healthcare provision has the potential to 
trigger an error. This means that problems can occur 
in the practice, products, procedures or systems of 
healthcare provision which, in turn, could culminate 
in adverse events for the patients, including an adverse 
reaction to drugs. This reaction is defined by the World 
Health Organization (WHO) as “a response to a drug 
that is noxious and unintended and occurs at doses 
normally used in man for the prophylaxis, diagnosis or 
therapy of disease, or for modification of physiological 
function”.2 Although other terminologies have been 
used to describe unwanted effects of drugs, such as 
‘toxic effect’ or ‘side-effect’, the term ‘adverse effect’ 
is currently the most preferred.3 Pharmacovigilance 
is “the science and activities relating to the detection, 
assessment, understanding and prevention of adverse 
effects or any other drug-related problem”.2
The importance of patient safety with regards to 
drug use has been translated into many policies and 
actions by the WHO, such as the initiation of the 
Quality Assurance and Safety of Medicines (QSM) 
team to address worldwide drug safety and drug 
utilisation. The QSM team function to encourage 
member states to participate in the WHO International 
Drug Monitoring Programme.2 A second important 
milestone is the work of the WHO Collaborating 
Centre for International Drug Monitoring, located 
in Uppsala, Sweden, which maintains a database for 
reports of suspected adverse drug reactions from the 
member states.4 These initiatives strive to promote 
pharmacovigilance at national levels with the objectives 
of improving patient care and safety with regards to the 
use of medications. This aim is actioned by supporting 
public health programmes through “providing reliable, 
balanced information for the effective assessment of the 
risk-benefit profile of medicines”.4
The above-mentioned international and local level 
initiatives have the potential to safeguard the use of 
medications and indeed are vital for consumer safety 
and protection. However, Jose et al.’s study suggests 
some significant gaps in the Omani public’s awareness 
regarding the use of medication that need to be 
addressed. Their study clearly indicates that the public 
harbour a view that runs counter to international best 
practice.1 Therefore, concerted efforts are needed 
to increase public knowledge in alignment with the 
international best practice as stipulated by the WHO. 
Jose et al.’s study found that the Omani public believe 
that drug side-effects occur only with high doses, 
implying that the public would take the liberty to titrate 
dosage if deemed ‘high’.1 Conversely, it is also possible 
that a perceived ‘low’ dosage would be deemed ‘safe’. 
Such erroneous views could be a recipe for hindering 
compliance with treatment and observation for 
possible side-effects.
The WHO reported a ‘‘50% phenomenon’’, 
indicating that half of patients do not follow treatment 
recommendations.5 Indeed, according to the National 
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Institute for Health and Clinical Excellence, both 
high and low dosages are detrimental to health.6 
In a systematic review, van Gaalen et al. suggested 
that a failure to abide by the required dosage tends 
to put the patient at higher risk of an adverse drug 
reaction.7 According to the UK-based company, 
Patient Connect Service Limited, patients who take 
preventative medicines, such as those prescribed for 
an asymptomatic condition, are likely to fall prey to 
poor compliance as the preventative nature of the 
medication means they “do not feel immediately 
threatened”.8 If the patient has no overt symptoms, the 
chance of poor compliance increases or the concept of 
a ‘drug holiday’ comes to the forefront. 
In addition to the issue of an adverse drug reaction, 
Jose et al.’s study indicated that the majority of the 
public in Oman deemed traditional medicines to cause 
few or no adverse reactions. Most disheartening was 
that, in another study, such a view was also endorsed 
by medical students in Oman.9 This means that sub-
optimal knowledge not only exists among the general 
public, but also among those who are going to be the 
vanguard of health in the country–medical students. A 
major source of confusion is that traditional medicines 
are often parcelled as ‘food supplements’ which can 
evoke the ‘romance of a herbal elixir’. Although there 
are studies that have reported the therapeutic effects 
of some herbal medications,10 other studies have 
revealed that traditional medicinal products contain 
banned pesticides, microbial contaminants, heavy 
metals, chemical toxins or orthodox drugs.11 In fact, 
the medical literature is rife with documentation on the 
toxic effects stemming from traditional medicine.12,13 
There is a wide misconception that herbal medicines 
are derived from natural sources and are therefore non-
toxic and safe. On this ground, there is a significant 
disjunction between what medical science has revealed 
about herbal medicine and public perception.
There are a number of implicit implications 
behind the prevailing romance with herbal medicine, 
including potential delays in medical intervention 
and the abandonment of biomedical treatment. It has 
been found that a tendency to use both treatment 
modalities simultaneously has the potential to 
compromise the efficiency of medical treatment.14 
In Oman, traditional medicines are reportedly often 
consumed concurrently with prescription medication 
from a medical doctor.15,16 Such ‘cocktails’ have the 
potential to do more harm than good. For this matter 
WHO recommends that all member states should: 
‘A) Establish, strengthen and implement an 
effective regulation of providers of herbal medicines in 
respect of their qualifications. B) Establish, strengthen 
and effectively enforce regulations on herbal medicines. 
C) Strengthen capacity-building efforts for providers, 
manufactures and regulators of herbal medicines in 
order to improve their capacity and expertise regarding 
assurance of safety and quality of herbal medicines. 
D) Include safety monitoring of herbal medicines in 
pharmacovigilance systems and promote the awareness 
of consumers/patients on safety aspects of herbal 
medicines. E) Provide technical support to Member 
States in the implementation in particular regarding 
the safety of herbal medicines and of traditional and 
complementary medicine practices.17
Due to the rise of chronic and lifestyle diseases 
in Oman,12 emerging medical conditions require a 
more novel approach than the existing ‘cure-oriented’ 
healthcare system.18,19 By virtue of the chronic nature of 
a lifestyle disease, and as these diseases are often being 
impervious to available biomedical care, those afflicted 
by these diseases may be more inclined to utilise 
both allopathic medicine and alternative medicine. 
Such ‘dual loyalty’ likely stems from emerging health 
education where patients are encouraged to work 
with their own doctor.20 With this emerging trend, 
a concerted effort is needed to impart to both the 
public and medical experts alike the pros and cons of 
both healthcare systems. Health education in Oman 
appears to represent a middle way between these two 
contesting parties. In the midst of such a predicament, 
perhaps we should take note of the words of T. S. Eliot: 
“we shall not cease from exploration, and the end of all 
our exploring will be to arrive where we started and 
know the place for the first time”.21
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